| Title : Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease - Ruthirakuhan_2016_Expert.Opin.Pharmacother_17_2417 |
| Author(s) : Ruthirakuhan M , Herrmann N , Suridjan I , Abraham EH , Farber I , Lanctot KL |
| Ref : Expert Opin Pharmacother , 17 :2417 , 2016 |
| Abstract : |
| PubMedSearch : Ruthirakuhan_2016_Expert.Opin.Pharmacother_17_2417 |
| PubMedID: 27825018 |
| Title : Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments - Liu_2016_Curr.Alzheimer.Res_13_1134 |
| Author(s) : Liu CS , Ruthirakuhan M , Chau SA , Herrmann N , Carvalho AF , Lanctot KL |
| Ref : Curr Alzheimer Res , 13 :1134 , 2016 |
| Abstract : |
| PubMedSearch : Liu_2016_Curr.Alzheimer.Res_13_1134 |
| PubMedID: 27137221 |
| Title : A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease - Herrmann_2016_J.Am.Med.Dir.Assoc_17_142 |
| Author(s) : Herrmann N , O'Regan J , Ruthirakuhan M , Kiss A , Eryavec G , Williams E , Lanctot KL |
| Ref : J Am Med Dir Assoc , 17 :142 , 2016 |
| Abstract : |
| PubMedSearch : Herrmann_2016_J.Am.Med.Dir.Assoc_17_142 |
| PubMedID: 26482056 |